Caixin
Apr 30, 2022 08:00 AM

China Resources Double-Crane Pharmaceutical Co.,Ltd.’s Net Profit Rose 16.2% in First Quarter of 2022

China Resources Double-Crane Pharmaceutical Co.,Ltd. (华润双鹤药业股份有限公司) (600062.SH) reported a net profit of 345.4 million yuan in the first quarter of 2022, up 16.2% year-on-year.

Meanwhile, the company posted 2.5 billion yuan in revenue, up 4.6% year-on-year.

At the end of the reporting period, it had 13.7 billion yuan in total assets and 3.2 billion yuan in total liabilities, with a liability-to-asset ratio of 23.2%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
China Business Uncovered Podcast: Brazil’s ‘Very Chinese Moment’
00:00
00:00/00:00